{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:00:40Z","timestamp":1787731240819,"version":"build-2784847793"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The lung is one of several organs that can be affected by HTLV-1 mediated inflammation. Pulmonary inflammation associated with HTLV-1 infection involves the interstitium, airways and alveoli, resulting in several clinical entities including interstitial pneumonias, bronchiolitis and alveolitis, depending on which structures are most affected. Augmentation of the inflammatory effects of HTLV-1 infected lymphocytes by recruitment of other inflammatory cells in a positive feedback loop is likely to underlie the pathogenesis of HTLV-1 associated pulmonary disease, as has been proposed for HTLV-1 associated myelopathy. In contrast to the conclusions of early case series, HTLV-1 associated pulmonary disease can be associated with significant parenchymal damage, which may progress to bronchiectasis where this involves the airways. Based on our current understanding of HTLV-1 associated pulmonary disease, diagnostic criteria are proposed.<\/jats:p>","DOI":"10.1186\/s12977-020-00543-z","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T18:03:54Z","timestamp":1609956234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-6083","authenticated-orcid":false,"given":"Lloyd","family":"Einsiedel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Chiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus","family":"Jersmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"4","key":"543_CR1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"543_CR2","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77(12):7415\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"543_CR3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7(4):266\u201381.","journal-title":"Lancet Infect Dis"},{"key":"543_CR4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012;3:388.","journal-title":"Front Microbiol"},{"issue":"9","key":"543_CR5","doi-asserted-by":"crossref","first-page":"e2418","DOI":"10.1371\/journal.pntd.0002418","volume":"7","author":"O Cassar","year":"2013","unstructured":"Cassar O, Einsiedel L, Afonso PV, Gessain A. Human T-cell lymphotropic virus type 1 subtype C molecular variants among indigenous australians: new insights into the molecular epidemiology of HTLV-1 in Australo-Melanesia. PLoS Negl Trop Dis. 2013;7(9):e2418.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"543_CR6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0092-8674(03)00881-X","volume":"115","author":"N Manel","year":"2003","unstructured":"Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell. 2003;115(4):449\u201359.","journal-title":"Cell"},{"key":"543_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1742-4690-7-99","volume":"7","author":"D Ghez","year":"2010","unstructured":"Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O. Current concepts regarding the HTLV-1 receptor complex. Retrovirology. 2010;7:99.","journal-title":"Retrovirology"},{"issue":"39","key":"543_CR8","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1038\/sj.onc.1208972","volume":"24","author":"N Manel","year":"2005","unstructured":"Manel N, Battini JL, Taylor N, Sitbon M. HTLV-1 tropism and envelope receptor. Oncogene. 2005;24(39):6016\u201325.","journal-title":"Oncogene"},{"key":"543_CR9","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3389\/fmicb.2017.01425","volume":"8","author":"Y Tagaya","year":"2017","unstructured":"Tagaya Y, Gallo RC. The Exceptional Oncogenicity of HTLV-1. Front Microbiol. 2017;8:1425.","journal-title":"Front Microbiol"},{"issue":"10","key":"543_CR10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/aid.2006.22.931","volume":"22","author":"CM De Castro-Costa","year":"2006","unstructured":"De Castro-Costa CM, Araujo AQ, Barreto MM, Takayanagui OM, Sohler MP, da Silva EL, et al. Proposal for diagnostic criteria of tropical spastic paraparesis\/HTLV-I-associated myelopathy (TSP\/HAM). AIDS Res Hum Retroviruses. 2006;22(10):931\u20135.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"543_CR11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/infdis\/166.4.943","volume":"166","author":"M Mochizuki","year":"1992","unstructured":"Mochizuki M, Watanabe T, Yamaguchi K, Tajima K, Yoshimura K, Nakashima S, et al. Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies. J Infect Dis. 1992;166(4):943\u20134.","journal-title":"J Infect Dis"},{"issue":"2","key":"543_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0002-9394(14)73974-1","volume":"114","author":"M Mochizuki","year":"1992","unstructured":"Mochizuki M, Watanabe T, Yamaguchi K, Yoshimura K, Nakashima S, Shirao M, et al. Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol. 1992;114(2):123\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"543_CR13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1473-3099(19)30402-5","volume":"20","author":"G Schierhout","year":"2020","unstructured":"Schierhout G, McGregor S, Gessain A, Einsiedel L, Martinello M, Kaldor J. Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis. 2020;20(1):133\u201343.","journal-title":"Lancet Infect Dis"},{"key":"543_CR14","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.1038\/nrdp.2015.12","volume":"1","author":"CR Bangham","year":"2015","unstructured":"Bangham CR, Araujo A, Yamano Y, Taylor GP. HTLV-1-associated myelopathy\/tropical spastic paraparesis. Nat Rev Dis Primers. 2015;1:15012.","journal-title":"Nat Rev Dis Primers"},{"issue":"8727","key":"543_CR15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(90)92896-P","volume":"336","author":"L LaGrenade","year":"1990","unstructured":"LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet. 1990;336(8727):1345\u20137.","journal-title":"Lancet"},{"issue":"12","key":"543_CR16","first-page":"1519","volume":"13","author":"M de Lourdes Bastos","year":"2009","unstructured":"de Lourdes Bastos M, Osterbauer B, Mesquita DL, Carrera CA, Albuquerque MJ, Silva L, et al. Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis. Int J Tuberc Lung Dis. 2009;13(12):1519\u201323.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"543_CR17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2169\/internalmedicine.32.623","volume":"32","author":"T Matsuzaki","year":"1993","unstructured":"Matsuzaki T, Otose H, Hashimoto K, Shibata Y, Arimura K, Osame M. Diseases among men living in human T-lymphotropic virus type I endemic areas in Japan. Intern Med. 1993;32(8):623\u20138.","journal-title":"Intern Med"},{"issue":"1","key":"543_CR18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4269\/ajtmh.1999.60.146","volume":"60","author":"E Gotuzzo","year":"1999","unstructured":"Gotuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg. 1999;60(1):146\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"543_CR19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4269\/ajtmh.2006.74.246","volume":"74","author":"T Hirata","year":"2006","unstructured":"Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A, et al. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am J Trop Med Hyg. 2006;74(2):246\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"543_CR20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4269\/ajtmh.2005.72.855","volume":"72","author":"M Blas","year":"2005","unstructured":"Blas M, Bravo F, Castillo W, Castillo WJ, Ballona R, Navarro P, et al. Norwegian scabies in Peru: the impact of human T cell lymphotropic virus type I infection. Am J Trop Med Hyg. 2005;72(6):855\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"543_CR21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, et al. Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol. 1998;4(6):586\u201393.","journal-title":"J Neurovirol"},{"issue":"1\u20132","key":"543_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2005.05.010","volume":"237","author":"S Olindo","year":"2005","unstructured":"Olindo S, Lezin A, Cabre P, Merle H, Saint-Vil M, Edimonana Kaptue M, et al. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM\/TSP patients: a marker of disease progression. J Neurol Sci. 2005;237(1\u20132):53\u20139.","journal-title":"J Neurol Sci"},{"issue":"11","key":"543_CR23","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1586\/1744666X.2014.966690","volume":"10","author":"F Martin","year":"2014","unstructured":"Martin F, Taylor GP, Jacobson S. Inflammatory manifestations of HTLV-1 and their therapeutic options. Expert Rev Clin Immunol. 2014;10(11):1531\u201346.","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"543_CR24","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116(8):1211\u20139.","journal-title":"Blood"},{"issue":"1","key":"543_CR25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00042560-199909010-00012","volume":"22","author":"GP Taylor","year":"1999","unstructured":"Taylor GP, Tosswill JH, Matutes E, Daenke S, Hall S, Bain BJ, et al. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr. 1999;22(1):92\u2013100.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"543_CR26","first-page":"281","volume":"40","author":"I Kimura","year":"1986","unstructured":"Kimura I, Tsubota T, Tada S, Sogawa J. Presence of antibodies against adult T cell leukemia antigen in the patients with chronic respiratory diseases. Acta Med Okayama. 1986;40(6):281\u20134.","journal-title":"Acta Med Okayama"},{"issue":"8569","key":"543_CR27","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0140-6736(87)91362-6","volume":"2","author":"M Sugimoto","year":"1987","unstructured":"Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, et al. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet. 1987;2(8569):1220.","journal-title":"Lancet"},{"key":"543_CR28","first-page":"46","volume":"137","author":"I Maruyama","year":"1988","unstructured":"Maruyama I, Tihara J, Sakashita I, Mizoguti R, Mori S, Usuku K, et al. HTLV-1 associated broncho pneumopahty-a new clinical entity? Am Rev Respir Dis. 1988;137:46.","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"543_CR29","first-page":"787","volume":"30","author":"I Kimura","year":"1992","unstructured":"Kimura I. [HABA (HTLV-I associated bronchiolo-alveolar disorder)]. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30(5):787\u201395.","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"2","key":"543_CR30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00063198-199803000-00007","volume":"4","author":"M Sugimoto","year":"1998","unstructured":"Sugimoto M, Kitaichi M, Ikeda A, Nagai S, Izumi T. Chronic bronchioloalveolitis associated with human T-cell lymphotrophic virus type I infection. Curr Opin Pulm Med. 1998;4(2):98\u2013102.","journal-title":"Curr Opin Pulm Med"},{"issue":"8","key":"543_CR31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-109-8-625","volume":"109","author":"LJ Couderc","year":"1988","unstructured":"Couderc LJ, Caubarrere I, Venet A, Magdeleine J, Jouanelle A, Danon F, et al. Bronchoalveolar lymphocytosis in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1 (HTLV-1). Clinical, immunologic, and cytologic studies. Ann Intern Med. 1988;109(8):625\u20138.","journal-title":"Ann Intern Med"},{"issue":"8578","key":"543_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0140-6736(88)92744-4","volume":"1","author":"JC Vernant","year":"1988","unstructured":"Vernant JC, Buisson G, Magdeleine J, De Thore J, Jouannelle A, Neisson-Vernant C, et al. T-lymphocyte alveolitis, tropical spastic paresis, and Sjogren syndrome. Lancet. 1988;1(8578):177.","journal-title":"Lancet"},{"issue":"1","key":"543_CR33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1440-1827.1994.tb02582.x","volume":"44","author":"K Sueyoshi","year":"1994","unstructured":"Sueyoshi K, Goto M, Johnosono M, Sato E, Shibata D. Anatomical distribution of HTLV-I proviral sequence in an autopsy case of HTLV-I associated myelopathy: a polymerase chain reaction study. Pathol Int. 1994;44(1):27\u201333.","journal-title":"Pathol Int"},{"issue":"151","key":"543_CR34","doi-asserted-by":"crossref","first-page":"180122","DOI":"10.1183\/16000617.0122-2018","volume":"28","author":"SC Zimmermann","year":"2019","unstructured":"Zimmermann SC, Tonga KO, Thamrin C. Dismantling airway disease with the use of new pulmonary function indices. Eur Respir Rev. 2019;28(151):180122.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"543_CR35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2249.2004.02485.x","volume":"136","author":"M Yamamoto","year":"2004","unstructured":"Yamamoto M, Matsuyama W, Oonakahara K, Watanabe M, Higashimoto I, Kawabata M, et al. Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis. Clin Exp Immunol. 2004;136(3):513\u201320.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"543_CR36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2249.2003.02240.x","volume":"133","author":"W Matsuyama","year":"2003","unstructured":"Matsuyama W, Kawabata M, Mizoguchi A, Iwami F, Wakimoto J, Osame M. Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis-HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity. Clin Exp Immunol. 2003;133(3):397\u2013403.","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"543_CR37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00042560-199600001-00002","volume":"13","author":"N Mueller","year":"1996","unstructured":"Mueller N, Okayama A, Stuver S, Tachibana N. Findings from the Miyazaki Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(Suppl 1):2\u20137.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"1","key":"543_CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3201\/eid1001.020714","volume":"10","author":"EL Murphy","year":"2004","unstructured":"Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, et al. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis. 2004;10(1):109\u201316.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"543_CR39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5694\/mja16.00285","volume":"205","author":"LJ Einsiedel","year":"2016","unstructured":"Einsiedel LJ, Pham H, Woodman RJ, Pepperill C, Taylor KA. The prevalence and clinical associations of HTLV-1 infection in a remote Indigenous community. Med J Aust. 2016;205(7):305\u20139.","journal-title":"Med J Aust"},{"issue":"1","key":"543_CR40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/cid\/cir766","volume":"54","author":"L Einsiedel","year":"2012","unstructured":"Einsiedel L, Fernandes L, Spelman T, Steinfort D, Gotuzzo E. Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population. Clin Infect Dis. 2012;54(1):43\u201350.","journal-title":"Clin Infect Dis"},{"key":"543_CR41","doi-asserted-by":"crossref","unstructured":"Einsiedel L, Pham H, Au V, Hatami S, Wilson K, Spelman T, et al. Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study. ERJ Open Res. 2019;5(4).","DOI":"10.1183\/23120541.00001-2019"},{"issue":"8","key":"543_CR42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/resp.13280","volume":"23","author":"SR Blackall","year":"2018","unstructured":"Blackall SR, Hong JB, King P, Wong C, Einsiedel L, Remond MGW, et al. Bronchiectasis in indigenous and non-indigenous residents of Australia and New Zealand. Respirology. 2018;23(8):743\u20139.","journal-title":"Respirology"},{"issue":"1","key":"543_CR43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1081\/COPD-200050685","volume":"2","author":"PT King","year":"2005","unstructured":"King PT, Holdsworth SR, Freezer NJ, Villanueva E, Gallagher M, Holmes PW. Outcome in adult bronchiectasis. COPD. 2005;2(1):27\u201334.","journal-title":"COPD"},{"issue":"1","key":"543_CR44","doi-asserted-by":"crossref","first-page":"e2643","DOI":"10.1371\/journal.pntd.0002643","volume":"8","author":"L Einsiedel","year":"2014","unstructured":"Einsiedel L, Spelman T, Goeman E, Cassar O, Arundell M, Gessain A. Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population. PLoS Negl Trop Dis. 2014;8(1):e2643.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"543_CR45","doi-asserted-by":"crossref","first-page":"ofu023","DOI":"10.1093\/ofid\/ofu023","volume":"1","author":"L Einsiedel","year":"2014","unstructured":"Einsiedel L, Cassar O, Goeman E, Spelman T, Au V, Hatami S, et al. Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study. Open Forum Infect Dis. 2014;1(1):ofu023.","journal-title":"Open Forum Infect Dis"},{"issue":"8855","key":"543_CR46","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(93)91186-P","volume":"341","author":"LC Mollison","year":"1993","unstructured":"Mollison LC, Lo ST, Marning G. HTLV-I and scabies in Australian aborigines. Lancet. 1993;341(8855):1281\u20132.","journal-title":"Lancet"},{"issue":"3","key":"543_CR47","doi-asserted-by":"crossref","first-page":"e0006281","DOI":"10.1371\/journal.pntd.0006281","volume":"12","author":"L Einsiedel","year":"2018","unstructured":"Einsiedel L, Pham H, Wilson K, Walley R, Turpin J, Bangham C, et al. Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians. PLoS Negl Trop Dis. 2018;12(3):e0006281.","journal-title":"PLoS Negl Trop Dis"},{"key":"543_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1401","author":"L Einsiedel","year":"2020","unstructured":"Einsiedel L, Pham H, Talukder MRR, Liddle J, Taylor K, Wilson K, et al. Pulmonary disease is associated with human T-cell leukaemia virus type 1c infection: a cross-sectional survey in remote Aboriginal Australian communities. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1401.","journal-title":"Clin Infect Dis"},{"key":"543_CR49","doi-asserted-by":"crossref","first-page":"e00714","DOI":"10.1016\/j.idcr.2020.e00714","volume":"19","author":"F Chiong","year":"2020","unstructured":"Chiong F, Jersmann H, Wilson K, Einsiedel L. HTLV-1c associated bronchiolitis in an Aboriginal man from central Australia. IDCases. 2020;19:e00714.","journal-title":"IDCases"},{"key":"543_CR50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12879-015-1002-0","volume":"15","author":"S Honarbakhsh","year":"2015","unstructured":"Honarbakhsh S, Taylor GP. High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease. BMC Infect Dis. 2015;15:258.","journal-title":"BMC Infect Dis"},{"key":"543_CR51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/bmj.320.7235.611","volume":"320","author":"J Tosswill","year":"1999","unstructured":"Tosswill J, Taylor G, Tedder R, Mortimer P. HTLV-1 associated disease in England and Wales 1993\u20131997: a retrospective study of serology requestes. BMJ. 1999;320:611\u20132.","journal-title":"BMJ"},{"issue":"Suppl 1","key":"543_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1\u201369.","journal-title":"Thorax"},{"issue":"11","key":"543_CR53","doi-asserted-by":"crossref","first-page":"e0186055","DOI":"10.1371\/journal.pone.0186055","volume":"12","author":"LF Magno Falcao","year":"2017","unstructured":"Magno Falcao LF, Falcao ASC, Medeiros Sousa RC, Vieira WB, de Oliveira RTM, Normando VMF, et al. CT Chest and pulmonary functional changes in patients with HTLV-associated myelopathy in the Eastern Brazilian Amazon. PLoS ONE. 2017;12(11):e0186055.","journal-title":"PLoS ONE"},{"issue":"5","key":"543_CR54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thorax.55.5.388","volume":"55","author":"W Matsuyama","year":"2000","unstructured":"Matsuyama W, Mizoguchi A, Iwami F, Koreeda Y, Wakimoto J, Kanazawa H, et al. Clinical investigation of pulmonary Mycobacterium avium complex infection in human T lymphotrophic virus type I carriers. Thorax. 2000;55(5):388\u201392.","journal-title":"Thorax"},{"issue":"6","key":"543_CR55","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1086\/514143","volume":"176","author":"EL Murphy","year":"1997","unstructured":"Murphy EL, Glynn SA, Fridey J, Sacher RA, Smith JW, Wright DJ, et al. Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group. J Infect Dis. 1997;176(6):1468\u201375.","journal-title":"J Infect Dis"},{"issue":"12","key":"543_CR56","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2169\/internalmedicine.48.1918","volume":"48","author":"E Atsumi","year":"2009","unstructured":"Atsumi E, Yara S, Higa F, Hirata T, Haranaga S, Tateyama M, et al. Influence of human T lymphotropic virus type I infection on the etiology of community-acquired pneumonia. Intern Med. 2009;48(12):959\u201365.","journal-title":"Intern Med"},{"issue":"2","key":"543_CR57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1148\/radiol.2402050886","volume":"240","author":"F Okada","year":"2006","unstructured":"Okada F, Ando Y, Yoshitake S, Yotsumoto S, Matsumoto S, Wakisaka M, et al. Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1. Radiology. 2006;240(2):559\u201364.","journal-title":"Radiology"},{"issue":"8","key":"543_CR58","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.acra.2012.03.020","volume":"19","author":"T Yamashiro","year":"2012","unstructured":"Yamashiro T, Kamiya H, Miyara T, Gibo S, Ogawa K, Akamine T, et al. CT scans of the chest in carriers of human T-cell lymphotropic virus type 1: presence of interstitial pneumonia. Acad Radiol. 2012;19(8):952\u20137.","journal-title":"Acad Radiol"},{"key":"543_CR59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcv.2016.03.006","volume":"78","author":"L Einsiedel","year":"2016","unstructured":"Einsiedel L, Cassar O, Spelman T, Joseph S, Gessain A. Higher HTLV-1c proviral loads are associated with blood stream infections in an Indigenous Australian population. J Clin Virol. 2016;78:93\u20138.","journal-title":"J Clin Virol"},{"issue":"12","key":"543_CR60","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.rmed.2006.03.012","volume":"100","author":"PT King","year":"2006","unstructured":"King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006;100(12):2183\u20139.","journal-title":"Respir Med"},{"issue":"7","key":"543_CR61","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1183\/09031936.93.06070938","volume":"6","author":"M Sugimoto","year":"1993","unstructured":"Sugimoto M, Mita S, Tokunaga M, Yamaguchi K, Cho I, Matsumoto M, et al. Pulmonary involvement in human T-cell lymphotropic virus type-I uveitis: T-lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid. Eur Respir J. 1993;6(7):938\u201343.","journal-title":"Eur Respir J"},{"issue":"2","key":"543_CR62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00296-009-0921-8","volume":"30","author":"H Yu","year":"2009","unstructured":"Yu H, Higa F, Yamadori I, Yara S, Tanimoto Y, Haranaga S, et al. Pulmonary complications in human T-cell lymphotropic virus type 1 carriers with Sjogren\u2019s syndrome, three case reports and literature review. Rheumatol Int. 2009;30(2):253\u20138.","journal-title":"Rheumatol Int"},{"issue":"1","key":"543_CR63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13550289509111010","volume":"1","author":"M Nakagawa","year":"1995","unstructured":"Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol. 1995;1(1):50\u201361.","journal-title":"J Neurovirol"},{"issue":"6","key":"543_CR64","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/thx.2010.156919","volume":"66","author":"M Fujii","year":"2011","unstructured":"Fujii M, Sumi Y, Atarashi K, Takemura T, Inase N. Muscle weakness in extremities and diffuse centrilobular nodules in lungs. HTLV-1-associated bronchiolo-alveolar disorder. Thorax. 2011;66(6):546\u20137, 52.","journal-title":"Thorax"},{"issue":"4","key":"543_CR65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2169\/internalmedicine.35.305","volume":"35","author":"T Kikuchi","year":"1996","unstructured":"Kikuchi T, Saijo Y, Sakai T, Abe T, Ohnuma K, Tezuka F, et al. Human T-cell lymphotropic virus type I (HTLV-I) carrier with clinical manifestations characteristic of diffuse panbronchiolitis. Intern Med. 1996;35(4):305\u20139.","journal-title":"Intern Med"},{"issue":"9","key":"543_CR66","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/00365540410022639","volume":"36","author":"O Matsuno","year":"2004","unstructured":"Matsuno O, Watanabe K, Kataoka H, Miyazaki E, Kumamoto T. A case of diffuse panbronchiolitis (DPB) in a patient positive for HTLV-1. Scand J Infect Dis. 2004;36(9):687\u20139.","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"543_CR67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ajh.2830300207","volume":"30","author":"K Ono","year":"1989","unstructured":"Ono K, Shimamoto Y, Matsuzaki M, Sano M, Yamaguchi T, Kato O, et al. Diffuse panbronchiolitis as a pulmonary complication in patients with adult T-cell leukemia. Am J Hematol. 1989;30(2):86\u201390.","journal-title":"Am J Hematol"},{"issue":"3","key":"543_CR68","first-page":"228","volume":"41","author":"M Shinkai","year":"2003","unstructured":"Shinkai M, Kobayashi H, Saito W, Ohara I, Kanoh S, Motoyoshi K, et al. A case of HTLV-1-associated bronchiolitis with Sjogren\u2019s syndrome. Nihon Kokyuki Gakkai Zasshi. 2003;41(3):228\u201332.","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"issue":"12","key":"543_CR69","first-page":"1011","volume":"44","author":"M Uji","year":"2006","unstructured":"Uji M, Matsushita H, Watanabe T, Suzumura T. A human T-cell lymphotropic virus type 1 carrier presenting with Sjogren\u2019s syndrome and bronchopneumopathy. Nihon Kokyuki Gakkai Zasshi. 2006;44(12):1011\u20135.","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"issue":"2","key":"543_CR70","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/pin.12030","volume":"63","author":"J Fukuoka","year":"2013","unstructured":"Fukuoka J, Tominaga M, Ichikado K, Tanaka T, Ichiyasu H, Kohrogi H, et al. Lung miliary micro-nodules in human T-cell leukemia virus type I carriers. Pathol Int. 2013;63(2):108\u201312.","journal-title":"Pathol Int"},{"issue":"13","key":"543_CR71","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1080\/10428194.2019.1627543","volume":"60","author":"A Acuna-Villaorduna","year":"2019","unstructured":"Acuna-Villaorduna A, Gonzalez-Lugo J, Ye BH, Adrianzen Herrera DA, Sica RA, Shah U, et al. High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia\/lymphoma-implications for staging. Leuk Lymphoma. 2019;60(13):3272\u20136.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"543_CR72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000196184","volume":"60","author":"K Tamura","year":"1993","unstructured":"Tamura K, Yokota T, Mashita R, Tamura S. Pulmonary manifestations in adult T-cell leukemia at the time of diagnosis. Respiration. 1993;60(2):115\u20139.","journal-title":"Respiration"},{"issue":"5","key":"543_CR73","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10156-009-0707-7","volume":"15","author":"H Yu","year":"2009","unstructured":"Yu H, Fujita J, Higa F, Yamadori I, Hibiya K, Yara S, et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement in human T-cell lymphotropic virus type 1 carriers. J Infect Chemother. 2009;15(5):284\u20137.","journal-title":"J Infect Chemother"},{"issue":"1","key":"543_CR74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2169\/internalmedicine1962.30.15","volume":"30","author":"K Sugisaki","year":"1991","unstructured":"Sugisaki K, Nakazato O, Tsuda T, Okajima T. Lymphocytic infiltrations in the lung of two autopsy cases with HTLV-I-associated myelopathy. Jpn J Med. 1991;30(1):15\u201320.","journal-title":"Jpn J Med"},{"issue":"3","key":"543_CR75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jcp.46.3.273","volume":"46","author":"H Kuwabara","year":"1993","unstructured":"Kuwabara H, Katanaka J, Nagai M, Uda H, Hojo W, Yamada A, et al. Human T lymphotropic virus type I associated myelopathy with pulmonary and cutaneous lesions. J Clin Pathol. 1993;46(3):273\u20135.","journal-title":"J Clin Pathol"},{"issue":"6","key":"543_CR76","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4269\/ajtmh.1998.58.721","volume":"58","author":"K Sugisaki","year":"1998","unstructured":"Sugisaki K, Tsuda T, Kumamoto T, Akizuki S. Clinicopathologic characteristics of the lungs of patients with human T cell lymphotropic virus type 1-associated myelopathy. Am J Trop Med Hyg. 1998;58(6):721\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"23","key":"543_CR77","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2169\/internalmedicine.54.4717","volume":"54","author":"H Yamakawa","year":"2015","unstructured":"Yamakawa H, Yoshida M, Yabe M, Ishikawa T, Takagi M, Tanoue S, et al. Human T-cell lymphotropic virus type-1 (HTLV-1)-associated bronchioloalveolar disorder presenting with mosaic perfusion. Intern Med. 2015;54(23):3039\u201343.","journal-title":"Intern Med"},{"issue":"8","key":"543_CR78","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/crad.2001.0677","volume":"56","author":"U Tateishi","year":"2001","unstructured":"Tateishi U, Nishihara H, Miyasaka K. HTLV-1-associated bronchopneumonopathy (HAB): CT-pathological correlation. Clin Radiol. 2001;56(8):664\u20136.","journal-title":"Clin Radiol"},{"issue":"1","key":"543_CR79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/atm.ATM_204_19","volume":"15","author":"M Yamasaki","year":"2020","unstructured":"Yamasaki M, Taniwaki M, Funaishi K, Hattori N. Organizing pneumonia in a carrier of human T-cell lymphotropic virus type-1. Ann Thorac Med. 2020;15(1):41\u20133.","journal-title":"Ann Thorac Med"},{"key":"543_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-3-1","volume":"3","author":"EL Murphy","year":"2003","unstructured":"Murphy EL, Ownby HE, Smith JW, Garratty G, Hutching ST, Wu Y, et al. Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study. BMC Pulm Med. 2003;3:1.","journal-title":"BMC Pulm Med"},{"issue":"7","key":"543_CR81","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/jmv.23307","volume":"84","author":"T Kawabata","year":"2012","unstructured":"Kawabata T, Higashimoto I, Takashima H, Izumo S, Kubota R. Human T-lymphotropic virus type I (HTLV-I)-specific CD8+ cells accumulate in the lungs of patients infected with HTLV-I with pulmonary involvement. J Med Virol. 2012;84(7):1120\u20137.","journal-title":"J Med Virol"},{"issue":"4","key":"543_CR82","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1590\/S0004-282X1995000500009","volume":"53","author":"K Mattos","year":"1995","unstructured":"Mattos K, Melo A, Queiroz C, Publio L, Pecanha-Martins AC, Freitas V, et al. Pulmonary involvement in patients with HTLV-I associated myelopathy. Arq Neuropsiquiatr. 1995;53(4):766\u201370.","journal-title":"Arq Neuropsiquiatr"},{"issue":"2","key":"543_CR83","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4269\/ajtmh.1993.48.170","volume":"48","author":"S Mita","year":"1993","unstructured":"Mita S, Sugimoto M, Nakamura M, Murakami T, Tokunaga M, Uyama E, et al. Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy. Am J Trop Med Hyg. 1993;48(2):170\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"23","key":"543_CR84","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2169\/internalmedicine.52.0845","volume":"52","author":"Y Nakayama","year":"2013","unstructured":"Nakayama Y, Yamazato Y, Tamayose M, Atsumi E, Yara S, Higa F, et al. Increased expression of HBZ and Foxp3 mRNA in bronchoalveolar lavage cells taken from human T-lymphotropic virus type 1-associated lung disorder patients. Intern Med. 2013;52(23):2599\u2013609.","journal-title":"Intern Med"},{"issue":"3","key":"543_CR85","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2249.2000.01237.x","volume":"120","author":"M Seki","year":"2000","unstructured":"Seki M, Higashiyama Y, Mizokami A, Kadota J, Moriuchi R, Kohno S, et al. Up-regulation of human T lymphotropic virus type 1 (HTLV-1) tax\/rex mRNA in infected lung tissues. Clin Exp Immunol. 2000;120(3):488\u201398.","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"543_CR86","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/508899","volume":"194","author":"N Kwaan","year":"2006","unstructured":"Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, et al. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis. 2006;194(11):1557\u201364.","journal-title":"J Infect Dis"},{"issue":"1","key":"543_CR87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1348-0421.1994.tb01744.x","volume":"38","author":"H Mukae","year":"1994","unstructured":"Mukae H, Kohno S, Morikawa N, Kadota J, Matsukura S, Hara K. Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM\/TSP patients and HTLV-I carriers. Microbiol Immunol. 1994;38(1):55\u201362.","journal-title":"Microbiol Immunol"},{"issue":"1","key":"543_CR88","first-page":"17","volume":"32","author":"H Mukae","year":"1994","unstructured":"Mukae H, Higashiyama Y, Morikawa T, Kusano S, Morikawa N, Kadota J, et al. Association between diffuse panbronchiolitis and HTLV-I infection. Nihon Kyobu Shikkan Gakkai Zasshi. 1994;32(1):17\u201324.","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"1","key":"543_CR89","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/infdis\/160.1.162","volume":"160","author":"C Desgranges","year":"1989","unstructured":"Desgranges C, Bechet JM, Couderc LJ, Caubarrere I, Vernant JC. Detection of HTLV-1 DNA by polymerase chain reaction in alveolar lymphocytes of patients with tropical spastic paraparesis. J Infect Dis. 1989;160(1):162\u20133.","journal-title":"J Infect Dis"},{"issue":"2","key":"543_CR90","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/thx.2004.021667","volume":"60","author":"S Mori","year":"2005","unstructured":"Mori S, Mizoguchi A, Kawabata M, Fukunaga H, Usuku K, Maruyama I, et al. Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers. Thorax. 2005;60(2):138\u201343.","journal-title":"Thorax"},{"issue":"2","key":"543_CR91","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2249.1994.tb06541.x","volume":"96","author":"Y Higashiyama","year":"1994","unstructured":"Higashiyama Y, Katamine S, Kohno S, Mukae H, Hino S, Miyamoto T, et al. Expression of human T lymphotropic virus type 1 (HTLV-1) tax\/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals. Clin Exp Immunol. 1994;96(2):193\u2013201.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"543_CR92","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtcvs.2008.12.050","volume":"138","author":"S Yara","year":"2009","unstructured":"Yara S, Fujita J, Date H. Transmission of human T-lymphotropic virus type I by bilateral living-donor lobar lung transplantation. J Thorac Cardiovasc Surg. 2009;138(1):255\u20136.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"543_CR93","doi-asserted-by":"crossref","first-page":"e01063","DOI":"10.1128\/JCM.01063-18","volume":"57","author":"D Yurick","year":"2019","unstructured":"Yurick D, Khoury G, Clemens B, Loh L, Pham H, Kedzierska K, et al. Multiplex droplet digital PCR assay for quantification of human T-Cell leukemia virus type 1 subtype c DNA proviral load and T cells from blood and respiratory exudates sampled in a remote setting. J Clin Microbiol. 2019;57(2):e01063-18.","journal-title":"J Clin Microbiol."},{"issue":"2","key":"543_CR94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1440-1843.1996.tb00023.x","volume":"1","author":"T Matsuse","year":"1996","unstructured":"Matsuse T, Fukuchi Y, Hsu CY, Nagase T, Higashimoto N, Teramoto S, et al. Detection of human T lymphotropic virus type I proviral DNA in patients with diffuse panbronchiolitis. Respirology. 1996;1(2):139\u201344.","journal-title":"Respirology"},{"issue":"6","key":"543_CR95","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1378\/chest.124.6.2283","volume":"124","author":"Y Yamazato","year":"2003","unstructured":"Yamazato Y, Miyazato A, Kawakami K, Yara S, Kaneshima H, Saito A. High expression of p40(tax) and pro-inflammatory cytokines and chemokines in the lungs of human T-lymphotropic virus type 1-related bronchopulmonary disorders. Chest. 2003;124(6):2283\u201392.","journal-title":"Chest"},{"issue":"3","key":"543_CR96","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1365-2249.1999.01093.x","volume":"118","author":"M Seki","year":"1999","unstructured":"Seki M, Kadota JI, Higashiyama Y, Iida K, Iwashita T, Sasaki E, et al. Elevated levels of beta-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1). Clin Exp Immunol. 1999;118(3):417\u201322.","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"543_CR97","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/v10120691","volume":"10","author":"N Futsch","year":"2018","unstructured":"Futsch N, Prates G, Mahieux R, Casseb J, Dutartre H. Cytokine networks dysregulation during HTLV-1 infection and associated diseases. Viruses. 2018;10(12):691.","journal-title":"Viruses"},{"key":"543_CR98","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fmicb.2020.00421","volume":"11","author":"R Zargari","year":"2020","unstructured":"Zargari R, Mahdifar M, Mohammadi A, Vahidi Z, Hassanshahi G, Rafatpanah H. The role of chemokines in the pathogenesis of HTLV-1. Front Microbiol. 2020;11:421.","journal-title":"Front Microbiol"},{"issue":"3","key":"543_CR99","first-page":"121","volume":"22","author":"M Liu","year":"2011","unstructured":"Liu M, Guo S, Hibbert JM, Jain V, Singh N, Wilson NO, et al. CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011;22(3):121\u201330.","journal-title":"Cytokine Growth Factor Rev"},{"key":"543_CR100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1742-4690-5-86","volume":"5","author":"H Teruya","year":"2008","unstructured":"Teruya H, Tomita M, Senba M, Ishikawa C, Tamayose M, Miyazato A, et al. Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules. Retrovirology. 2008;5:86.","journal-title":"Retrovirology"},{"issue":"3","key":"543_CR101","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.rmed.2003.09.015","volume":"98","author":"N Sakamoto","year":"2004","unstructured":"Sakamoto N, Mukae H, Fujii T, Kakugawa T, Kaida H, Kadota J, et al. Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1. Respir Med. 2004;98(3):213\u20139.","journal-title":"Respir Med"},{"issue":"Pt 12","key":"543_CR102","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1099\/jmm.0.033456-0","volume":"60","author":"Y Nakayama","year":"2011","unstructured":"Nakayama Y, Ishikawa C, Tamaki K, Senba M, Fujita J, Mori N. Interleukin-1 alpha produced by human T-cell leukaemia virus type I-infected T cells induces intercellular adhesion molecule-1 expression on lung epithelial cells. J Med Microbiol. 2011;60(Pt 12):1750\u201361.","journal-title":"J Med Microbiol"},{"issue":"3","key":"543_CR103","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.coi.2006.03.012","volume":"18","author":"JE Kohlmeier","year":"2006","unstructured":"Kohlmeier JE, Woodland DL. Memory T cell recruitment to the lung airways. Curr Opin Immunol. 2006;18(3):357\u201362.","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"543_CR104","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1378\/chest.118.6.1754","volume":"118","author":"M Seki","year":"2000","unstructured":"Seki M, Higashiyama Y, Kadota J, Mukae H, Yanagihara K, Tomono K, et al. Elevated levels of soluble adhesion molecules in sera and BAL fluid of individuals infected with human T-cell lymphotropic virus type 1. Chest. 2000;118(6):1754\u201361.","journal-title":"Chest"},{"issue":"4","key":"543_CR105","doi-asserted-by":"crossref","first-page":"e1003263","DOI":"10.1371\/journal.ppat.1003263","volume":"9","author":"NA Gillet","year":"2013","unstructured":"Gillet NA, Cook L, Laydon DJ, Hlela C, Verdonck K, Alvarez C, et al. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. PLoS Pathog. 2013;9(4):e1003263.","journal-title":"PLoS Pathog"},{"key":"543_CR106","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","volume":"36","author":"CRM Bangham","year":"2018","unstructured":"Bangham CRM. Human T. Cell leukemia virus type 1: persistence and pathogenesis. Annu Rev Immunol. 2018;36:43\u201371.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"543_CR107","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/ajrccm.160.3.9808125","volume":"160","author":"K Kawakami","year":"1999","unstructured":"Kawakami K, Miyazato A, Iwakura Y, Saito A. Induction of lymphocytic inflammatory changes in lung interstitium by human T lymphotropic virus type I. Am J Respir Crit Care Med. 1999;160(3):995\u20131000.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"543_CR108","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-2249.2000.01197.x","volume":"120","author":"A Miyazato","year":"2000","unstructured":"Miyazato A, Kawakami K, Iwakura Y, Saito A. Chemokine synthesis and cellular inflammatory changes in lungs of mice bearing p40tax of human T-lymphotropic virus type 1. Clin Exp Immunol. 2000;120(1):113\u201324.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"543_CR109","doi-asserted-by":"crossref","first-page":"e1001274","DOI":"10.1371\/journal.ppat.1001274","volume":"7","author":"Y Satou","year":"2011","unstructured":"Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011;7(2):e1001274.","journal-title":"PLoS Pathog"},{"issue":"9","key":"543_CR110","doi-asserted-by":"crossref","first-page":"e1003630","DOI":"10.1371\/journal.ppat.1003630","volume":"9","author":"N Yamamoto-Taguchi","year":"2013","unstructured":"Yamamoto-Taguchi N, Satou Y, Miyazato P, Ohshima K, Nakagawa M, Katagiri K, et al. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. PLoS Pathog. 2013;9(9):e1003630.","journal-title":"PLoS Pathog"},{"key":"543_CR111","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2016.08.012","volume":"304","author":"Y Yamano","year":"2017","unstructured":"Yamano Y, Coler-Reilly A. HTLV-1 induces a Th1-like state in CD4(+)CCR4(+) T cells that produces an inflammatory positive feedback loop via astrocytes in HAM\/TSP. J Neuroimmunol. 2017;304:51\u20135.","journal-title":"J Neuroimmunol"},{"issue":"Pt 9","key":"543_CR112","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1093\/brain\/awt183","volume":"136","author":"H Ando","year":"2013","unstructured":"Ando H, Sato T, Tomaru U, Yoshida M, Utsunomiya A, Yamauchi J, et al. Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. Brain. 2013;136(Pt 9):2876\u201387.","journal-title":"Brain"},{"issue":"10","key":"543_CR113","doi-asserted-by":"crossref","first-page":"e2479","DOI":"10.1371\/journal.pntd.0002479","volume":"7","author":"T Sato","year":"2013","unstructured":"Sato T, Coler-Reilly A, Utsunomiya A, Araya N, Yagishita N, Ando H, et al. CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis. PLoS Negl Trop Dis. 2013;7(10):e2479.","journal-title":"PLoS Negl Trop Dis"},{"key":"543_CR114","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev-immunol-032712-100019","volume":"31","author":"K Chen","year":"2013","unstructured":"Chen K, Kolls JK. T cell-mediated host immune defenses in the lung. Annu Rev Immunol. 2013;31:605\u201333.","journal-title":"Annu Rev Immunol"},{"key":"543_CR115","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev-pathol-012615-044344","volume":"11","author":"RJ Boyton","year":"2016","unstructured":"Boyton RJ, Altmann DM. Bronchiectasis: current concepts in pathogenesis, immunology, and microbiology. Annu Rev Pathol. 2016;11:523\u201354.","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"543_CR116","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","volume":"188","author":"PJ McShane","year":"2013","unstructured":"McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188(6):647\u201356.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"543_CR117","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pulmoe.2019.02.004","volume":"25","author":"M Taniwaki","year":"2019","unstructured":"Taniwaki M, Yamasaki M, Matsumoto Y, Matsumoto N, Ohashi N, Hattori N. Corticosteroid therapy for organizing pneumonia in a human T-cell lymphotropic virus type-1 carrier. Pulmonology. 2019;25(3):193\u20135.","journal-title":"Pulmonology"},{"issue":"1","key":"543_CR118","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2169\/internalmedicine.56.6995","volume":"56","author":"N Yokohori","year":"2017","unstructured":"Yokohori N, Sato A, Hasegawa M, Katsura H, Hiroshima K, Takemura T. Effectiveness of combined therapy with pirfenidone and erythromycin for unclassifiable interstitial pneumonia induced by HTLV-1-associated bronchioloalveolar disorder (HABA). Intern Med. 2017;56(1):73\u20138.","journal-title":"Intern Med"},{"issue":"4","key":"543_CR119","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1378\/chest.125.4.1239","volume":"125","author":"J Kadota","year":"2004","unstructured":"Kadota J, Mukae H, Fujii T, Seki M, Tomono K, Kohno S. Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis. Chest. 2004;125(4):1239\u201347.","journal-title":"Chest"}],"updated-by":[{"DOI":"10.1186\/s12977-021-00549-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000}}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-020-00543-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12977-020-00543-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-020-00543-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T20:08:11Z","timestamp":1670702891000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-020-00543-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["543"],"URL":"https:\/\/doi.org\/10.1186\/s12977-020-00543-z","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12977-021-00549-1","asserted-by":"object"}]},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12977-021-00549-1","URL":"https:\/\/doi.org\/10.1186\/s12977-021-00549-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}